Automated Summary
Key Facts
The Competition Tribunal of South Africa approved the acquisition of Emerald Insurance Company Limited and Emerald Risk Transfer (Pty) Ltd by Santam Limited on 30 October 2009. The merger involves Santam acquiring 100% of Emerald's shares from Super Group and 62% of ERT's shares from management. Post-merger, Emerald's short-term insurance licence will be run-off, and its insurance book transferred to Santam. The Tribunal concluded no significant competition concerns in the overall short-term corporate insurance market, as AIG and Mutual & Federal (M&F) remain major competitors. New entrants like ABSA and RMB are expected to provide follow market capacity. The merged entity's market share is projected to decrease post-merger, but the Tribunal expressed skepticism about this predicted decline.
Issues
- The merging parties claimed Emerald's capital constraints rendered it ineffective, while the Commission acknowledged its historical effectiveness. The Tribunal found Emerald's recent ineffectiveness claims were short-term and tied to Super Group's actions, with no evidence of systemic harm. It concluded Emerald remains a credible competitor despite its challenges.
- The Tribunal assessed whether Emerald qualifies as a failing firm, considering its financial position, regulatory non-compliance, and potential for reorganisation. Super Group's financial difficulties were found to be the root cause of Emerald's regulatory issues, and the Commission initially argued Emerald's likely failure but later withdrew this claim. The Tribunal concluded no factual basis exists to label Emerald as a failing firm.
- The Commission predicted a post-merger decline in the merged entity's market share due to reduced capacity, but the Tribunal dismissed this as short-sighted. It emphasized the presence of competitors like AIG and M&F, along with potential new entrants (ABSA, RMB), and concluded the merger would not create significant competition concerns in the overall market.
- The Tribunal examined if the lead market (where Santam, AIG, and M&F dominate) is a separate relevant market. While Emerald's role in the lead market was limited, the analysis found no sufficient evidence to conclude the merger would harm competition in this potential sub-market. Entry barriers and broker dynamics were key considerations.
Holdings
- The Tribunal concluded that the merger would not remove Emerald as an effective competitor in the short term corporate insurance sector. While Emerald's role as a lead insurer is limited compared to Santam and AIG, its underwriting model and intellectual capital could still be preserved or replicated by other market participants. The overlap in shared accounts between Santam and Emerald was deemed insufficient to justify significant market share reduction post-merger.
- The Tribunal rejected the Commission's claim that Emerald meets the criteria of a 'failing firm' under the Competition Act, noting that Emerald's financial difficulties stem from Super Group's broader financial issues rather than its own operational failures. It emphasized that Super Group has viable options to reorganize Emerald, including recapitalization and reinsurance programs, and that Emerald remains a credible competitor despite its current regulatory challenges.
- No significant public interest issues were identified as a result of the proposed merger. The Tribunal also dismissed concerns about reduced countervailing power from brokers or clients, as no concrete examples were provided to substantiate this claim.
- The Competition Tribunal approved the acquisition of Emerald Insurance Company Limited and Emerald Risk Transfer (Pty) Ltd by Santam Limited, finding no significant competition concerns in the overall short term corporate insurance market or potential follow market. The Tribunal concluded that the merger would not substantially prevent or lessen competition, as multiple competitors remain active post-merger, including AIG and Mutual & Federal, and potential new entrants like ABSA and RMB could provide additional follow capacity.
Remedies
The Competition Tribunal of South Africa approved the acquisition by Santam Limited of Emerald Insurance Company Limited and Emerald Risk Transfer (Pty) Ltd on 30 October 2009. The decision concluded that the merger would not substantially prevent or lessen competition in the short term corporate insurance market, citing sufficient competition from remaining players like AIG and Mutual & Federal, and the potential for new entrants such as ABSA and RMB. The Tribunal also noted no significant public interest issues arising from the transaction.
Legal Principles
The Competition Tribunal emphasized that the burden of proof for invoking the failing firm doctrine lies with the merging parties. This includes demonstrating (i) the firm's likely failure, (ii) the absence of realistic reorganisation options, and (iii) no less anticompetitive alternative purchaser. The Tribunal found no factual basis to conclude Emerald was a failing firm despite its regulatory challenges.
Precedent Name
- Merger Guidelines of the Office of Fair Trading of the United Kingdom
- Iscor Limited and Saldanha Steel (Pty) Ltd
- 1997 Horizontal Merger Guidelines
- Horizontal Merger Guidelines (2004/C31/03)
Cited Statute
- Competition Act, 1998
- Short-Term Insurance Act, 1998
Judge Name
- N Manoim
- A Ndoni
- A Wessels
Passage Text
- [88] Although the merged entity would be the largest player post merger in the South African overall short term corporate insurance market, various competitors remain active in that market post merger... This alleviates any likely unilateral or co-ordinated post merger competition concerns in a potential follow market.
- [1] On 30 October 2009, the Competition Tribunal ("Tribunal") approved the acquisition by Santam Limited of Emerald Insurance Company Limited and Emerald Risk Transfer (Pty) Ltd. The reasons for approval follow.
- [102] Since there is no evidence of a likely substantial prevention or lessening of competition in any (potential) relevant market as a result of the proposed deal, and also no significant public interest issues arising from this deal, we accordingly approve the transaction without conditions.